Structure and Function of Small Arteries of Essential Hypertensive Patients Following Chronic Treatment with Once-a-Day Nifedipine

Cardiology (Switzerland)

Volumn 88, Issue , 1997, Pages 20-26

  Schiffrin, Ernesto L ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Atenolol; Endothelium; Essential hypertension; Hypertrophy; Nifedipine GITS; Small arteries; Vascular remodeling

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; NIFEDIPINE;

ADULT; AGED; ARTERIAL PRESSURE; ARTERY; ARTERY DIAMETER; ARTERY DILATATION; ARTERY MUSCLE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GLUTEUS MAXIMUS MUSCLE; HUMAN; HUMAN TISSUE; LONG TERM CARE; MALE; MORBIDITY; MORTALITY; MUSCLE BIOPSY; MYOGRAPHY; PRIORITY JOURNAL; RESISTANCE BLOOD VESSEL; SMOOTH MUSCLE CONTRACTILITY; STRUCTURE ACTIVITY RELATION; SUSTAINED RELEASE PREPARATION; VASCULAR ENDOTHELIUM;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ARTERIOLES; ATENOLOL; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; NIFEDIPINE; RANDOMIZED CONTROLLED TRIALS;

EID: 0030821050     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000177502     Document Type: Article

References (36)

1. Folkow B: Physiological aspects of primary hypertension. Physiol Rev 1982:62:347-504.
2. Mulvany MJ. Aalkjaer C: Structure and function of small arteries. Physiol Rev 1990;70: 921-971.
3. Spence JD: Cerebral consequences of hypertension: in Laragh JH. Brenner BM (eds): Pathophysiology, Diagnosis and Management, ed 2. New York, Raven Press, 1995. pp 741-753.
4. Ruilope LM, Aleázar JM, Rodicio JL: Renal consequences of hypertension. J Hvpertens 1992;10(suppl 7):S85-S90.
5. Brush JE, Cannon RO. Schenke WH. Bonow RO, Leon MB, Maron BJ, Epstein SE: Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 1988:319:1302-1307.
6. Fuster V. Badimon L. Badimon JJ, Chesebro JH: The pathogenesis of acute coronary syndromes. N Engl J Med 1992:326:242-250, 310-318.
7. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension. H. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA 1970;202:1143-1152.
8. Australian National Blood Pressure Study Management Committee: Australian Therapeutic Trial in Mild Hypertension. Lancet 1980;i: 1262-1267.
9. Hypertension Detection and Follow-up Program Cooperative Group: The effect of treatment on mortality in mild hypertension. N Engl J Med 1982;307:976-980.
10. Medical Research Council Working Party: MRC trial of treatment of mild hypertension: Principal results. Br Med J 1985;291:97-104.
11. Medical Research Council Working Party: MRC trial of treatment of hypertension in older adults: Principal results. Br Med J 1992:304: 405-412.
12. MacMahon SW, Cutler JA, Stander J: Antihypertensive drug treatment. Potential, expected, and observed effects on stroke and on coronary heart disease. Hypertension 1989;13(suppl 1): 1-45-1-50.
13. Collins R, Peto R, MacMahon S. Herbert P. Fiebach NH, Eberlcin KA, Godwin J. Kizil-bach N. Taylor JO. Hennekens CH: Blood pressure, stroke, and coronary heart disease, Part 2. Short term reductions in blood pressure: Overview of randomized drug trials in their epidemiological context. Lancet 1990;335: 827-838.
14. Schiffrin EL, Deng LY, Larochelle P: Effects of a beta blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 1994;23:83-91.
15. Schiffrin EL. Deng LY, Larochelle P: Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin l-converting enzyme inhibitor. Comparison with effects of a beta blocker. Am J Hypertcns 1995:8:229-236.
16. Thybo NK, Stephens N, Cooper A, Aalkjaer C, Heagerty AM, Mulvany MJ: Effect of antihy-pertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995;25:474-481.
17. Schiffrin EL. Deng LY: Comparison of effects of angiotensin I-convcrting enzyme inhibition and beta blockade on function of small arteries from hypertensive patients. Hypertension 1995;25:699-703.
18. Schiffrin EL. Deng LY: Structure and function of resistance arteries of hypertensive patients treated with a P-blocker or a calcium channel antagonist.! Hypertens 1996;14:1247-1255.
19. Aalkjaer C. Heagerty AM. Petersen KK. Swales JD. Mulvany MJ: Evidence for increased media thickness, increased neuronal amine uptake. and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res 1987;61:181-186.
20. Schiffrin EL. Deng LY, Larochelle P: Morphology of resistance arteries and comparison of effects of vasoconstrictors in mild essential hypertensive patients. Clin Invest Med 1993; 16: 177-186.
21. Thybo NK, Korsgaard N, Erikscn S, Christensen KL, Mulvany MJ: Dose-dependent effects of perindopril on blood pressure and small-artery structure. Hypertension 1994;23:659-666.
22. Li J-S. Schiffrin EL: Chronic endolhelin receptor antagonist treatment of young spontaneously hypertensive rats. J Hvpertens 1995; 13:647-652.
23. Li J-S, Schiffrin EL: Effect of calcium channel blockade or angiotensin converting enzyme inhibition on structure of coronary, renal and other small arteries in SHR. J Cardiovasc Pharmacol 1996;28:68-74.
24. Baumbach GL, Heistad DD: Remodeling of cerebral arterioles in chronic hypertension. Hypertension 1989:13:968-972.
25. Falloon BJ, Bund SJ. Tulip JR, Heagerty AM: In vitro perfusion studies of resistance artery function in genetic hypertension. Hypertension 1993;22:486-495.
26. Touyz RM. Deng LY, Schiffrin EL: Endothelin subtype B receptor-mediated calcium and contractile responses in small arteries of hypertensive rats. Hypertension 1995;26:1041-1045.
27. Falloon BJ, Stephens N, Tulip JR. Heagerty AM: Comparison of small artery sensitivity and morphology in pressurized and wire-moented preparations. Am J Physiol 1995:268: H670-H678.
28. Agabiti Rosei E. Rizzoni D. Castellano M. Ported E, Zulli R, Muiesan ML. Bettoni G, Salvet-ti M. Muiesan P. Giulini SM: Mediadumen ratio in human small resistance arteries is related to forearm minimal vascular resistance. J Hypertens 1995:13:349-355.
29. Panza JA. Quyyumi AA, Brush JE. Epstein SE: Abnormal endothelium dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990:323:22-27.
30. Deng LY. Li J-S. Schiffrin EL: Endothelium-dependent relaxation of small arteries from essential hypertensive patients. Clin Sci 1995; 88:611-622.
31. Lund-Johansen P, Ornvik P: Acute and chronic effects of drugs with different actions on adrenergic receptors: A comparison between alpha blockers and different types of beta blockers with and without vasodilating effect. Cardiovasc Drugs Ther 1991;5:605-615.
32. Hajdu MA, Heistad DD. Baumbach GL: Effects of antihypertensive therapy on mechanics of cerebral arterioles in rats. Hypertension 1991:17:308-316.
33. Baumbach GL: Effects of increased pulse pressure on cerebral arterioles. Hypertension 1996; 27:159-167.
34. Korsgaard N, Aalkjær C. Heagerty AM. Izzard AS, Mulvany MJ: Histology of subcutaneous small arteries from patients with essential hypertension. Hypertension 1993;22:523-526.
35. Mulvany MJ. Baumbach GL Aalkjaer C, Heagerty AM. Korsgaard N, Schiffrin EL. Heistad DD: Vascular remodeling. Hypertension 1996; 28:505-506.
36. Motz W. Strauer BE: Improvement of coronary flow reserve after long-term therapy with enala-pril. Hypertension 1996;27:1031-1038.